| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.10B | 11.65B | 9.09B | 5.05B | 5.27B | 5.16B |
| Gross Profit | 3.33B | 3.67B | 3.64B | -858.28M | 174.46M | 1.33B |
| EBITDA | 2.79B | 3.35B | 3.05B | -1.20B | -87.56M | 1.06B |
| Net Income | 1.73B | 1.87B | 2.56B | -1.06B | -40.16M | 762.40M |
Balance Sheet | ||||||
| Total Assets | 54.50B | 50.71B | 49.01B | 36.55B | 33.96B | 30.82B |
| Cash, Cash Equivalents and Short-Term Investments | 7.72B | 6.21B | 6.48B | 5.86B | 7.16B | 6.73B |
| Total Debt | 2.23B | 1.89B | 1.96B | 1.17B | 1.17B | 1.14B |
| Total Liabilities | 35.53B | 33.16B | 33.45B | 26.69B | 23.78B | 19.87B |
| Stockholders Equity | 11.50B | 10.57B | 9.45B | 5.33B | 6.62B | 7.56B |
Cash Flow | ||||||
| Free Cash Flow | 3.99B | 4.16B | 1.91B | 1.12B | 2.05B | 4.30B |
| Operating Cash Flow | 3.99B | 4.16B | 1.91B | 1.60B | 1.23B | 1.99B |
| Investing Cash Flow | -2.58B | -3.06B | -3.82B | -3.02B | -816.30M | -2.30B |
| Financing Cash Flow | -1.26B | -1.29B | 2.59B | 725.34M | -302.46M | 665.21M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $2.65B | 6.16 | 17.62% | ― | 22.79% | -5.17% | |
77 Outperform | $12.56B | 7.62 | 14.98% | 0.57% | -3.96% | -48.08% | |
76 Outperform | $2.32B | 12.63 | 8.09% | ― | 7.87% | -4.68% | |
74 Outperform | $12.77B | 15.02 | 7.19% | 1.76% | 2.10% | 19.23% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | $13.43B | 23.96 | 3.59% | 2.37% | 8.62% | -78.92% | |
63 Neutral | $458.98M | -282.88 | -0.28% | ― | 5.83% | -101.38% |
On December 22, 2025, Citibank Europe and several RenaissanceRe group companies executed an amendment to their secured letter of credit facility, extending the facility’s availability end date to December 31, 2026 and its expiry date to December 31, 2027, while keeping all other terms unchanged. The facility continues to provide up to $320 million in letters of credit, with the option to increase capacity to $350 million subject to conditions, underscoring the group’s continued access to bank-backed collateral support and reinforcing its financial flexibility and operational capacity in the reinsurance and specialty insurance markets.
The most recent analyst rating on (RNR) stock is a Hold with a $281.00 price target. To see the full list of analyst forecasts on Renaissancere Holdings stock, see the RNR Stock Forecast page.